Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Angiographic and Intravascular Ultrasound (IVUS) Follow-up After Simultaneously Implanted Different Drug-eluting Stents in Same Individuals (AIFSIDDES)

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified September 2009 by Liuhuaqiao Hospital.
Recruitment status was:  Recruiting
Information provided by:
Liuhuaqiao Hospital Identifier:
First received: September 8, 2009
Last updated: NA
Last verified: September 2009
History: No changes posted
The purpose of this study is to investigate if there is any different follow-up results by angiography and IVUS between two different drug-eluting stents after implanted simultaneously in same individuals.

Drug Eluting Stent

Study Type: Observational
Study Design: Observational Model: Case Control
Time Perspective: Cross-Sectional

Further study details as provided by Liuhuaqiao Hospital:

Primary Outcome Measures:
  • Segment and instent restenosis measured by coronary angiography and IVUS. [ Time Frame: at 12 months after implantation ]

Secondary Outcome Measures:
  • Uncovered and malposition of stent. [ Time Frame: at 12 months after implantation. ]

Estimated Enrollment: 30
Study Start Date: May 2009
Endeavor group and Excel group
Endeavor group: measurements from the vessels implanted Endeavor stent(s). Excel group: measurements from the vessels implanted Excel stent(s).


Ages Eligible for Study:   18 Years to 75 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
These patients who received two kinds of drug-eluting stent (Endeavor and Excel) im simultaneously.

Inclusion Criteria:

  • These patients who received two kinds of drug-eluting stent (Endeavor and Excel) im simultaneously.

Exclusion Criteria:

  • Dual anti-platelet therapy less than 12 months.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00973375

China, Guangdong
Liuhuaqiao Hospital Recruiting
Guangzhou, Guangdong, China, 510010
Contact: Dingcheng Xiang, MD, Ph.D    +86-20-3665 3325   
Principal Investigator: Dingcheng Xiang, MD, Ph.D         
Sponsors and Collaborators
Liuhuaqiao Hospital
  More Information